Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Trade Desk, Inc. | Director | Class A Common Stock | 96.9K | $9.51M | $98.17 | Aug 13, 2024 | Direct |
Trade Desk, Inc. | Director | Class A Common Stock | 50K | $4.91M | $98.17 | Aug 13, 2024 | By Family Trust |
Arcus Biosciences, Inc. | Director | Common Stock | 102K | $1.79M | $17.55 | Jun 6, 2024 | By Trust |
Arcus Biosciences, Inc. | Director | Common Stock | 55.3K | $971K | $17.55 | Jun 6, 2024 | Direct |
Trade Desk, Inc. | Director | Class B Common Stock | 0 | $0 | $82.36 | Mar 8, 2024 | Direct |
Nuvation Bio Inc. | Director | Stock Option (Right to Buy) | 201K | Sep 3, 2024 | Direct | ||
Tricida, Inc. | Director | Stock Option (right to buy) | 27.2K | Jun 15, 2022 | Direct | ||
Arcus Biosciences, Inc. | Director | Stock Option (Right to Buy) | 24K | Jun 6, 2024 | Direct | ||
UroGen Pharma Ltd. | Director | Stock Option (right to buy) | 10K | Jun 7, 2021 | Direct | ||
Trade Desk, Inc. | Director | Employee Stock Option Exercise (Right to Buy) | 0 | Mar 8, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NUVB | Nuvation Bio Inc. | Sep 3, 2024 | 1 | $0 | 4 | Sep 5, 2024 | Director |
TTD | Trade Desk, Inc. | Aug 13, 2024 | 1 | -$14.7M | 4 | Aug 15, 2024 | Director |
RCUS | Arcus Biosciences, Inc. | Jun 6, 2024 | 2 | $0 | 4 | Jun 7, 2024 | Director |
TTD | Trade Desk, Inc. | May 28, 2024 | 3 | $99.9K | 4 | May 30, 2024 | Director |
TTD | Trade Desk, Inc. | Mar 8, 2024 | 6 | -$8.25M | 4 | Mar 12, 2024 | Director |
RCUS | Arcus Biosciences, Inc. | Jun 15, 2023 | 3 | $0 | 4 | Jun 16, 2023 | Director |
TTD | Trade Desk, Inc. | May 25, 2023 | 3 | $99.9K | 4 | May 30, 2023 | Director |
NUVB | Nuvation Bio Inc. | May 15, 2023 | 1 | $0 | 4 | May 17, 2023 | Director |
TTD | Trade Desk, Inc. | Feb 6, 2023 | 0 | $0 | 4/A | Feb 9, 2023 | Director |
NUVB | Nuvation Bio Inc. | Nov 30, 2022 | 4 | $484K | 4 | Dec 5, 2022 | Director |
TCDA | Tricida, Inc. | Jun 15, 2022 | 1 | $0 | 4 | Jun 16, 2022 | Director |
RCUS | Arcus Biosciences, Inc. | Jun 14, 2022 | 2 | $0 | 4 | Jun 16, 2022 | Director |
TTD | Trade Desk, Inc. | May 26, 2022 | 4 | $70.9K | 4 | May 31, 2022 | Director |
NUVB | Nuvation Bio Inc. | May 16, 2022 | 1 | $0 | 4/A | Jun 28, 2022 | Director |
TTD | Trade Desk, Inc. | Nov 19, 2021 | 4 | -$16.3M | 4 | Nov 23, 2021 | Director |
NUVB | Nuvation Bio Inc. | Oct 29, 2021 | 1 | $0 | 4 | Nov 2, 2021 | Director |
TCDA | Tricida, Inc. | Jun 10, 2021 | 2 | $0 | 4 | Jun 11, 2021 | Director |
URGN | UroGen Pharma Ltd. | Jun 7, 2021 | 1 | $0 | 4 | Jun 9, 2021 | Director |
RCUS | Arcus Biosciences, Inc. | Jun 3, 2021 | 2 | $0 | 4 | Jun 7, 2021 | Director |
TTD | Trade Desk, Inc. | May 27, 2021 | 4 | $70.4K | 4 | Jun 1, 2021 | Director |